Placental growth factor as a screening tool of preeclampsia

Article Sidebar

PDF
Published: 2023-03-30
DOI: https://doi.org/10.18051/UnivMed.2023.v42.4-5
Keywords:
Placental Growth Factor

Main Article Content

Raditya Wratsangka
Department of Obstetrics and Gynaecology Faculty of Medicine, Universitas Trisakti, Jakarta, Indonesia
https://orcid.org/0000-0001-6254-8336

Article Details

Issue

Vol. 42 No. 1 (2023)

Section

Editorial
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.

How to Cite

Placental growth factor as a screening tool of preeclampsia. (2023). Universa Medicina, 42(1), 4-5. https://doi.org/10.18051/UnivMed.2023.v42.4-5

References

Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynecol Obstet 2019;145(S1):1–33. DOI: 10.1002/ijgo.12802.

Moungmaithong S, Wang X, Tai AST, et al. First trimester screening for preeclampsia: an asian perspective. Maternal-Fetal Medicine 2021;3: 116–23. DOI: 10.1002/ijgo.12802.

Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: A WHO secondary analysis. PLoS One 2014;9:e91198. doi: 10.1371/journal.pone.0091198.

Rana S, Lemoine E, Granger J, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res 2019;124:1094–112. doi: 10.1161/CIRCRESAHA.118.313276.

Mayrink J, Costa ML, Cecatti JG. Preeclampsia in 2018: revisiting concepts, physiopathology, and prediction. Scientific World Journal 2018;2018: 6268276. doi: 10.1155/2018/6268276.

O’Gorman N, Wright D, Syngelaki A, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. Am J Obstet Gynecol 2016;214:103.e1–e12. doi: 10.1016/j.ajog.2015. 08.034.

Boutin A, Demers S, Gasse C, et al. First-trimester placental growth factor for the prediction of preeclampsia in nulliparous women: the great obstetrical syndromes cohort study. Fetal Diagn Ther 2019;45:69–75. DOI: 10.1159/000487301.

Agrawal S, Shinar S, Cerdeira AS, Redman C, Vatish M. Predictive performance of PlGF (Placental Growth Factor) for screening preeclampsia in asymptomatic women: a systematic review and meta-analysis. Hypertension 2019;74:1124–35. DOI: 10.1161/HYPERTENSIONAHA.119.13360.

FIGO Working Group on Good Clinical Practice in Maternal-Fetal Medicine. Good clinical practice advice: first trimester screening and prevention of pre-eclampsia in singleton pregnancy. Int J Gynaecol Obstet 2019;144:325-29. doi: 10.1002/ijgo.12741.

National Institute for Health and Care Excellence (NICE). PLGF-based testing to help diagnose suspected preterm pre-eclampsia. National Institute for Health and Care Excellence; 2022.